Revolution Medicines, Inc. (RVMDW)
Biological Products, (No Diagnostic Substances)
Latest Price
$11.30
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
12.74
P/B Ratio
0.89
Institutional Ownership
4.8% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| LMR Partners LLP | 5.07M | $47.0M | 2.36% | +1.23M | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 1.58M | $14.0M | 0.74% | -- | 2026-06-30 |
| Sculptor Capital LP | 709.7K | $6.0M | 0.33% | -249.2K | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 579.5K | $5.0M | 0.27% | -- | 2026-06-30 |
| Caption Management, LLC | 517.7K | $4.0M | 0.24% | -- | 2026-06-30 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 500.0K | $4.0M | 0.23% | -- | 2026-06-30 |
| PERCEPTIVE ADVISORS LLC | 250.0K | $2.0M | 0.12% | -- | 2026-06-30 |
| Bleichroeder LP | 200.0K | $1.0M | 0.09% | -- | 2026-06-30 |
| WOLVERINE ASSET MANAGEMENT LLC | 154.5K | $1.0M | 0.07% | -16.2K | 2026-06-30 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 120.1K | $1.0M | 0.06% | -- | 2026-06-30 |